Hope, Health and Heart Tickets On Sale ❤️
Hope, Health and Heart Tickets On Sale ❤️
Valve disease care at the Minneapolis Heart Institute Foundation (MHIF) is driven by a multidisciplinary team of medical professionals. Our team includes renowned cardiac surgeons, cardiologists, imaging specialists, cardiac nurses, and researchers.
We collaborate to develop cutting-edge treatments for diseased heart valves: aortic, mitral, pulmonary, and tricuspid. The goal? To help valve disease patients enjoy healthier, longer lives.
In 2026, a generous $2 million charitable gift from the Bradshaw family established the James R. and Judith A. Bradshaw Chair for the Valve Science Center at MHIF. In 2017, a generous $2 million charitable gift from the Headrick family established the Roger L. and Lynn C. Headrick Family Chair, both supporting valve disease research, scientific publications and public education.
Heart valve disease occurs when heart valves aren’t working properly. They may be too stiff and narrow to open fully, which is called stenosis. Or the blood may leak through the heart valves, which is called regurgitation.
Faulty valves cause heart attacks, arrhythmias, congestive heart failure and other life-threatening conditions. More than 5 million Americans live with valve disease and many of them don’t know it. They may have no symptoms, or assume their lack of energy is a normal part of aging. Early diagnosis and treatment are key to helping valve disease patients lead healthier, fuller lives.
Aortic valves are flaps of tissue in the heart that act like a one-way door between the left ventricle and the aorta, the body’s main artery. When the heart pumps, the valve opens to let oxygen-rich blood flow out to the body, and then closes tightly to prevent blood from leaking backward into the heart.
The mitral valve is a flap-like structure in the heart that sits between the left atrium and left ventricle, acting as a one-way gate for blood flow. It has two leaflets that open when the left ventricle relaxes, allowing oxygen-rich blood to move from the atrium into the ventricle, and then close when the ventricle contracts to prevent blood from leaking backward.
The pulmonary valve is a semilunar heart valve that sits between the right ventricle and the pulmonary artery, acting like a one-way door for blood traveling to the lungs. When the right ventricle contracts, the valve opens to let oxygen-poor blood flow into the pulmonary artery, and when the heart relaxes, it closes to keep blood from leaking back into the ventricle.
MHIF conducts research in partnership with Allina Health Minneapolis Heart Institute physicians and the cardiovascular care center at Abbott Northwestern Hospital. These partnerships ensure that more patients receive lifesaving heart valve treatments, some of which are only available through research and clinical trials.
Darrell Kempfert had a leaky mitral valve, which left him out of breath and exhausted. Our team of valve specialists recommended a minimally invasive procedure to repair his leaky valve. After the transcatheter procedure, Darrell’s symptoms were gone and he felt ready to get back to golfing, playing pickleball, and enjoying life.
MHIF’s Valve Science Center team has authored hundreds of papers and presents frequently at national and international conferences.
Created by Dr. Vinayak Bapat as part of his passion for advancing patient care and sharing expertise, four valvular heart disease apps are currently available for physicians, focusing on learnings from research with advanced technologies and techniques.
Keep up to date on MHIF news, events and the latest information on heart disease treatment and prevention.